About X-TOSIS INC
X-tosis is a precision-medicine biotechnology company developing first-in-class mitochondrial therapeutics for neurodegenerative diseases such as Alzheimer's, Parkinson's, and ALS. Founded in 2024, the company focuses on disease-modifying therapies that target the root causes of neuronal loss.
Developing first-in-class mitochondrial therapeuticsAdvancing VDAC1-modulating compounds to restore mitochondrial functionUtilizing precision biomarkers for patient selection and treatment monitoringResearching disease-modifying approaches for neurodegenerative diseases
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to X-TOSIS INC right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.